Dr. Greenhawt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13123 E 16th Ave
Aurora, CO 80045Phone+1 720-777-1234Fax+1 720-777-7247
Education & Training
- University of MichiganFellowship, Allergy and Immunology, 2006 - 2008
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2001 - 2004
- Tufts University School of MedicineClass of 2001
Certifications & Licensure
- CO State Medical License 2015 - 2025
- MI State Medical License 2006 - 2016
- GA State Medical License 2008 - 2010
- NY State Medical License 2003 - 2008
- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Safe Administration of Flu Vaccine to Egg Allergic Children Start of enrollment: 2010 Oct 01
Publications & Presentations
PubMed
- Cost-effectiveness of oral immunotherapy for egg allergy according to age of therapy commencement.Melanie Lloyd, Jedidiah I Morton, Rachel L Peters, Paxton Loke, Sarah Ashley
The Journal of Allergy and Clinical Immunology. in Practice. 2024-12-13 - Thinking like a Bayesian: Diagnostic food allergy testing at the extremes of clinical certainty.Marcus S Shaker, Aikaterini Anagnostou, Matthew Greenhawt, Benjamin T Prince, Kristin Sokol
Annals of Allergy, Asthma & Immunology. 2024-12-04 - A health economic analysis of noninjectable epinephrine compared with intramuscular epinephrine.Marcus S Shaker, John Oppenheimer, Nicholas L Rider, David B K Golden, Aikaterini Anagnostou
Annals of Allergy, Asthma & Immunology. 2024-12-03
Journal Articles
- Achieving the Quadruple Aim to Deliver Value-Based Allergy Care in an Ever-Evolving Healthcare SystemMatthew Greenhawt, Marcus S Shaker, Annals of Allergy, Asthma & Immunology
- Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesMatthew Greenhawt, Marcus Shaker, Don A Bukstein, David M Fleischer, David R Stukus, Annals of Allergy, Asthma & Immunology
Authored Content
- Achieving the Quadruple Aim to Deliver Value-Based Allergy Care in an Ever-Evolving Healthcare SystemApril 2020
- Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesFebruary 2020
- Significant Health Care Cost Associated with Peanut Allergy Diagnostic CodesJanuary 2020
Press Mentions
- New Study on the Current State of Health Care for Eosinophilic EsophagitisMay 18th, 2023
- Peanut Allergy Skin Patch for Toddlers Shows Promise, Study FindsMay 12th, 2023
- Experimental Skin Patch Can Predict Peanut Allergy in Toddlers and Treat ItMay 11th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: